JANX Stock Analysis: Buy, Sell, or Hold?
JANX - Janux Therapeutics, Inc. Common Stock
$13.71
-0.12 (-0.87%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
26d
Get Alerted When JANX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called JANX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: JANX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: JANX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: JANX is currently trading at $13.71, which is considered extended relative to its 30-day fair value range of $13.56 to $14.42.
Technical Outlook: Technically, JANX is in a strong downtrend. Immediate support is located at $12.80, while resistance sits at $15.49.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $63.59 (+359.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, JANX is in a strong downtrend. Immediate support is located at $12.80, while resistance sits at $15.49.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $63.59 (+359.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$13.56 -
$14.42
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
Protect Your Profits
Holding JANX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 359.8% below Wall St target ($63.59)
- CAUTION: 5-day price weakness (-7.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$13.56 -
$14.42
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$12.80
Resistance Level
$15.49
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.65
Wall Street Target
$63.59
(+359.8%)
Revenue Growth (YoY)
2177.9%
Last updated: January 30, 2026 5:42 PM ET
Data refreshes hourly during market hours. Next update: 6:42 PM
Data refreshes hourly during market hours. Next update: 6:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JANX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced JANX Option Strategies
Professional options setups generated by AI based on today's JANX price and gamma walls.
